IMDEA Nanoscience representing NoCanTher at World Cancer Research Day in Madrid

Prof Alvaro Somoza participated in a number of events marking the launch of 24th September as World Cancer Research Day, an initiative created by the Asociación Española Contra el Cáncer.

The first event was the official launch of World Cancer Research Day, and a chance to meet the Queen of Spain who highlighted in her speech the importance of investigation in fight against cancer (Alvaro is pictured below with Her Majesty the Queen of Spain and M. Eugenio Vázquez).

Alvaro and Queen Compressed

On the day itself Prof Somoza got to meet members of the public in an event based in the famous Plaza del Museo Reina Sofía in central Madrid. The event was designed to shine a light on the investigation that is going on and help support this basic research (Luz A La Investigacion). During his talk he emphasized how nanomedicine has much to offer in developing new cancer treatments. Amongst his various projects, NoCanTher was highlighted as a great example of how various centres of investigation in Europe can come together to make a real difference.

AS Compressed 1 

The World Cancer Research Day initiative was originally designed to contribute to the objectives of the World Cancer Declaration in promoting cancer research and keeping its momentum going. It aims to accomplish the scientific advances that will lead towards achieving the goal that brings us together: to defeat cancer (source: aeec).

NoCanTher at CLINAM 2017

Our consortium had a great presence at CLINAM 2017 (10th European and Global Conference and Exhibition for Clinical Nanomedicine & Targeted Medicine). Adriele from TCD gave an overview of the project in his talk -NoCanTher project: clinical translation roadmap for iron oxide nanoparticles. Also present were Oihane and Ángel from Biopraxis and they mentioned the project as part of their talk -Nano‐onco: Biopraxis ROADMAP to Nanomedicine Translation for Cancer Treatment. Once again the project was seen by both a European and global audience of both researchers and clinicians.


The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience. 

Nano World Cancer Day 2017

NoCanTher had a strong presence at the NanoWorld Cancer Day (2nd February 2017), 15 countries united in providing information about smart nanotechnology solutions to beat cancer. We were highly visible across the day by the key participations of IMDEA, BIOPRAXIS, VHIR and TCD.

The Spanish event was hosted by one of the NoCanTher partners -Vall D’Hebron Institute of Oncology (VHIO), and featured three speakers from the NoCanTher consortium. Álvaro Somoza from IMDEA Nanociencia talked about using Nanomedicines against cancer encompassing basic research and clinical applications. Ángel del Pozo from Biopraxis then gave a different perspective talking about Nano-enabled therapy from an industrial point of view. Finally Teresa Macarulla from VHIO finished the session by giving us the clinical perspective of Nanotechnology. A panel discussion provided the opportunity to ask the experts questions about nanomedicines role in the fight against cancer.  The event was well attended both by the national press and members of the public, giving the NoCanTher project an excellent opportunity to reach a large and varied audience.



NoCanTher at Fira de Recerca en Direct 2017

More than 600 high school students have already had the chance to learn about our work with nanoparticles, our partners from Vall d'Hebron have been taking part in "Fira de Recerca Direct 2017" (Live Research Fair 2017). The fair is open to the general public (last day tomorrow 6th May), anyone can reach them at CosmoCaixa (Science museum in Barcelona, C/Isaac Newton 26). 

This event, organized by the Scientific Culture Unit of the Barcelona Science Park with "la Caixa" Foundation, aims to show the current research projects in Catalonia in different fields of research, bringing it to the public and promoting scientific vocation of young students.